COPD Trial, Recruiting NCT06578156 Sponsor: University of Miami Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06578156
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able to give their informed consent to participate
  • People aged 18 years or older
  • People who have been diagnosed with COPD (chronic obstructive pulmonary disease)
  • People who are able to walk around without help from another person or a mobility aid
  • People who use a low-flow nasal cannula (a small oxygen tube worn under the nose) at 4 litres per minute or less, or who do not use any supplemental oxygen at all

Who may not be able to join:

  • People who are pregnant
  • People who are on complete bed rest
  • People who are unable to give consent or cooperate with the study requirements
  • People who need more than 4 litres per minute of supplemental oxygen, or who require a breathing support machine (non-invasive ventilation) during the day
  • People with an unstable heart rate or blood pressure at rest — specifically a heart rate above 130 beats per minute, or a blood pressure that is too low (below 90 mmHg systolic) or too high (180 mmHg systolic or above)
  • People who have metal implants in the chest area, including pacemakers, implantable heart defibrillators (AICDs), or surgical hardware such as plates, screws, rods, or disc replacements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Saramaria Afanador Castiblanco, M.D., University of Miami

Phone: 305-243-2568

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 December 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

6-minute walk test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov